Target intelligence / Profile preview

Immunoglobulin heavy variable 3-20 (IGHV3-20)

Target
IGHV3-20
Molecular classification
Immunoglobulin variable region, Immunoglobulin superfamily, Other
01

Overview

Immunoglobulin heavy variable 3-20 (IGHV3-20) is a gene segment coding for the variable region of the heavy chain of immunoglobulins (antibodies)[1][5]. IGHV3-20 encodes the V (variable) domain of the antibody heavy chain, which is essential for forming the antigen-binding site together with the light chain variable region[1][3]. This variable region enables antigen recognition and binding, which is the fundamental activity of antibodies in humoral immunity. The specific sequence variability of IGHV3-20, shaped by V-(D)-J rearrangement and somatic hypermutation, contributes to the diversity and affinity maturation of antibodies produced by B lymphocytes[1][2][3]. IGHV3-20, like other IGHV genes, participates in immune defense by allowing plasma cells and B cells to generate highly variable and specific antibodies to a wide range of antigens[1][2]. IGHV gene polymorphisms, including those at IGHV3-20, can affect the breadth, potency, and specificity of immune responses in health and disease and are implicated in the context of infectious diseases, cancers (such as B-cell lymphomas), and other immune-related conditions[7][2]. However, IGHV3-20 itself is a germline gene segment and not a stand-alone protein, receptor, or drug target; its medical importance is indirect, relating to its contribution to antibody specificity and diversity rather than being a direct therapeutic target[1][7].

Other names
Immunoglobulin heavy variable 3-20IGHV3-20IGHV320VHimmunoglobulin heavy chain variable region
02

Biological functions

Antigen bindingImmune responseHumoral immunity
03

Disease associations

CancerInfectionImmune and autoimmune disordersOther

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-20 (IGHV3-20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-20 (IGHV3-20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call